UroGen Pharma Ltd (URGN)
13.66
-0.12
(-0.87%)
USD |
NASDAQ |
May 16, 12:04
UroGen Pharma Profit Margin (Quarterly): -110.6% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -110.6% |
| September 30, 2023 | -104.9% |
| June 30, 2023 | -114.2% |
| March 31, 2023 | -175.7% |
| December 31, 2022 | -159.6% |
| September 30, 2022 | -160.5% |
| June 30, 2022 | -160.8% |
| March 31, 2022 | -209.3% |
| December 31, 2021 | -175.9% |
| September 30, 2021 | -266.2% |
| June 30, 2021 | -201.2% |
| March 31, 2021 | -346.5% |
| December 31, 2020 | -383.2% |
| September 30, 2020 | -832.6% |
| June 30, 2020 | -8.43K% |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | -124.9K% |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | -7.26K% |
| June 30, 2018 | -4.95K% |
| March 31, 2018 | -2.78K% |
| December 31, 2017 | -3.08K% |
| September 30, 2017 | -3.81% |
| June 30, 2017 | |
| March 31, 2017 | -17.98K% |
| December 31, 2016 | 73.72% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-124.9K%
Minimum
Jun 2019
-104.9%
Maximum
Sep 2023
-8.54K%
Average
-188.6%
Median
Profit Margin (Quarterly) Benchmarks
| Agenus Inc | -221.0% |
| Exelixis Inc | 8.78% |
| Geron Corp | -18.22K% |
| Protalix BioTherapeutics Inc | -122.6% |
| InfuSystems Holdings Inc | -3.48% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -71.41% |
| Return on Invested Capital | -1.30K% |
| Gross Profit Margin (Quarterly) | 90.28% |
| Operating Margin (Quarterly) | -62.09% |
| Return on Net Operating Assets | -465.9% |